{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:13:44Z","timestamp":1790187224216,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227479","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T13:24:46Z","timestamp":1579267486000},"page":"e0227479","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical implications of elevated serum interleukin-6 in IgG4-related disease"],"prefix":"10.1371","volume":"15","author":[{"given":"Satoshi","family":"Tsukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ikeura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Nakamaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Ikemune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1131-4067","authenticated-orcid":true,"given":"Toshiro","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Terasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuichi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"issue":"3","key":"pone.0227479.ref001","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00535-012-0744-3","article-title":"Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system","volume":"48","author":"K Okazaki","year":"2013","journal-title":"J Gastroenterol"},{"issue":"1","key":"pone.0227479.ref002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","article-title":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011","volume":"22","author":"H Umehara","year":"2012","journal-title":"Mod Rheumatol"},{"issue":"12","key":"pone.0227479.ref003","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"PA Hart","year":"2013","journal-title":"Gut"},{"issue":"1","key":"pone.0227479.ref004","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","article-title":"Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis","volume":"139","author":"RP Sah","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0227479.ref005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004836-200603000-00007","article-title":"Prognostic values of IL-6, IL-8, and IL-10 in acute pancreatitis","volume":"40","author":"D Stimac","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"pone.0227479.ref006","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3109\/14397595.2013.844390","article-title":"Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease","volume":"24","author":"M Nara","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"7","key":"pone.0227479.ref007","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/kep098","article-title":"The analysis of interleukin-6 in patients with systemic IgG4-related plasmacytic syndrome\u2014expansion of SIPS to the territory of Castleman's disease","volume":"48","author":"M Yamamoto","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"pone.0227479.ref008","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2169\/internalmedicine.55.6919","article-title":"IgG4-related Disease Involving Multiple Organs with Elevated Serum Interleukin-6 Levels","volume":"55","author":"T Ikeura","year":"2016","journal-title":"Intern Med"},{"issue":"5","key":"pone.0227479.ref009","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes M","year":"2010","journal-title":"J Diabetes Investig"},{"issue":"1","key":"pone.0227479.ref010","first-page":"220","article-title":"Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis","volume":"102","author":"M Matsushita","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"pone.0227479.ref011","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00535-010-0361-y","article-title":"Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis","volume":"46","author":"T Tomiyama","year":"2011","journal-title":"J Gastroenterol"},{"issue":"3","key":"pone.0227479.ref012","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"A Masamune","year":"2017","journal-title":"Gut"},{"issue":"3","key":"pone.0227479.ref013","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/SHK.0000000000000616","article-title":"Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units","volume":"46","author":"W Takahashi","year":"2016","journal-title":"Shock"},{"issue":"9","key":"pone.0227479.ref014","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/ajg.2009.327","article-title":"Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients","volume":"104","author":"L Frulloni","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"pone.0227479.ref015","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"ZS Wallace","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"pone.0227479.ref016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V95.1.56","article-title":"Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy","volume":"95","author":"N Nishimoto","year":"2000","journal-title":"Blood"},{"issue":"23","key":"pone.0227479.ref017","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","article-title":"Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease","volume":"28","author":"F van Rhee","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"pone.0227479.ref018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/PAS.0000000000000575","article-title":"Multicentric Castleman Disease With Tubulointerstitial Nephritis Mimicking IgG4-related Disease: Two Case Reports","volume":"40","author":"T Zoshima","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"pone.0227479.ref019","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/his.13186","article-title":"Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease","volume":"70","author":"Y Terasaki","year":"2017","journal-title":"Histopathology"},{"issue":"4","key":"pone.0227479.ref020","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/modpathol.2009.17","article-title":"Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease","volume":"22","author":"Y Sato","year":"2009","journal-title":"Mod Pathol"},{"key":"pone.0227479.ref021","first-page":"76","article-title":"Clinicopathological Analysis between IgG4-related and Non-IgG4-related Diseases Occurring in Various Organs and Tissues: Re-evaluation of Comprehensive Diagnostic Criteria and Usefulness of Interleukin-6 Immunostaining","volume":"41","author":"N. Kurose","year":"2016","journal-title":"J Kanazawa Med Univ"},{"issue":"4","key":"pone.0227479.ref022","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2012.07.001","article-title":"Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity","volume":"29","author":"W Cheuk","year":"2012","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"pone.0227479.ref023","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-019-9070-7","article-title":"Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature","volume":"67","author":"H Kawashima","year":"2019","journal-title":"Immunologic research"},{"issue":"12","key":"pone.0227479.ref024","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00380-018-1203-8","article-title":"Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases","volume":"33","author":"S Kasashima","year":"2018","journal-title":"Heart Vessels"},{"issue":"4","key":"pone.0227479.ref025","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"AY Liu","year":"2016","journal-title":"Lancet Haematol"},{"issue":"6","key":"pone.0227479.ref026","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.18632\/oncotarget.24068","article-title":"Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease","volume":"9","author":"K Otani","year":"2018","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"pone.0227479.ref027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00535-010-0323-4","article-title":"Clinical significance of immunoglobulin G4-associated autoimmune hepatitis","volume":"46","author":"T Umemura","year":"2011","journal-title":"J Gastroenterol"},{"issue":"3","key":"pone.0227479.ref028","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2015.10.005","article-title":"Immunoglobulin G4-associated autoimmune hepatitis may be found in Western countries","volume":"48","author":"CM Canivet","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"5","key":"pone.0227479.ref029","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0168-8278(94)80251-3","article-title":"The nature and prognostic implications of autoimmune hepatitis with an acute presentation","volume":"21","author":"GA Nikias","year":"1994","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0227479.ref030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"H Tilg","year":"1992","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0227479.ref031","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2131\/jts.39.413","article-title":"Purinergic signaling via P2Y receptors up-mediates IL-6 production by liver macrophages\/Kupffer cells","volume":"39","author":"M Ishimaru","year":"2014","journal-title":"J Toxicol Sci"},{"issue":"3","key":"pone.0227479.ref032","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.blre.2008.10.001","article-title":"Splenomegaly: investigation, diagnosis and management","volume":"23","author":"AL Pozo","year":"2009","journal-title":"Blood Rev"},{"issue":"8","key":"pone.0227479.ref033","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00535-012-0692-y","article-title":"Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis","volume":"48","author":"H Matsubayashi","year":"2013","journal-title":"J Gastroenterol"},{"issue":"19","key":"pone.0227479.ref034","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.86.19.7547","article-title":"IgG1 plasmacytosis in interleukin 6 transgenic mice","volume":"86","author":"S Suematsu","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0227479.ref035","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/cyto.2002.2012","article-title":"Anti-interleukin 6 (IL-6) receptor antibody suppresses Castleman's disease like symptoms emerged in IL-6 transgenic mice","volume":"20","author":"A Katsume","year":"2002","journal-title":"Cytokine"},{"issue":"1","key":"pone.0227479.ref036","doi-asserted-by":"crossref","first-page":"e000432","DOI":"10.1136\/rmdopen-2017-000432","article-title":"Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease","volume":"3","author":"T Sasaki","year":"2017","journal-title":"RMD open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T13:25:04Z","timestamp":1579267504000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227479"}},"subtitle":[],"editor":[{"given":"John A.","family":"Chiorini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227479","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]}}}